Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

August 23, 2019

Primary Completion Date

April 26, 2022

Study Completion Date

April 26, 2022

Conditions
Obesity
Interventions
DEVICE

VeSTAL

The aim of this study is to evaluate the efficacy of non-invasive electrical vestibular nerve stimulation in combination with a lifestyle modification program, as a method of reducing excess body weight and body fat, as compared to a sham device in combination with the same lifestyle modification program.

Trial Locations (4)

78749

Texas Diabetes and Endocrinology, Austin

92093

UC San Diego, Exercise and Physical Activity Resource Center, La Jolla

University of California San Diego, Altman Clinical & Translational Research Institute,, La Jolla

Unknown

Univeristy of Ulster, Coleraine

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

collaborator

University of Ulster

OTHER

collaborator

Exploristics

UNKNOWN

collaborator

Compliance Solutions Ltd.

INDUSTRY

lead

Neurovalens Ltd.

INDUSTRY

NCT03640286 - Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial | Biotech Hunter | Biotech Hunter